No connection

Search Results

BGSF

BEARISH
$6.4 Live
BGSF, Inc. · NYSE
$2.91 52W Range $8.22

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$71.68M
P/E
N/A
ROE
-17.7%
Profit margin
-12.2%
Debt/Equity
0.02
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BGSF exhibits severe financial distress, as evidenced by a Piotroski F-Score of 2/9 (indicating weak financial health) and a lack of Altman Z-Score data, which raises bankruptcy risk concerns. The company reports negative profitability across all key metrics—ROE (-17.69%), ROA (-5.62%), and a -12.25% profit margin—while revenue has collapsed by 65.8% YoY. Despite a seemingly low Price/Book (1.49) and modest Price/Sales (0.77), the company’s deteriorating earnings trajectory and lack of sustainable growth undermine valuation appeal. Insider activity is neutral with no recent trades, and analyst coverage is absent, signaling minimal institutional interest. The stock’s recent 151.7% 1-year return appears speculative, driven by momentum rather than fundamentals.

Key Strengths

Strong liquidity position with a current ratio of 4.12 and quick ratio of 3.31
Very low debt/equity ratio (0.02), indicating minimal leverage risk
Gross margin of 35.72% suggests operational efficiency in cost of goods sold
Recent quarterly earnings have shown some positive surprises (e.g., +36.4% in 2025-05-07)
Price is below 52-week high ($8.22), offering a potential short-term technical bounce opportunity

Key Risks

Piotroski F-Score of 2/9 indicates extreme financial weakness and high risk of distress
Revenue declined 65.8% YoY, signaling severe business contraction
Negative ROE (-17.69%) and ROA (-5.62%) reflect poor capital utilization and declining profitability
No analyst coverage or target price, indicating lack of market confidence
Forward P/E of 53.33 is high relative to negative earnings, suggesting overvaluation if no recovery occurs

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
28
Weak
Value
40
Future
20
Past
55
Health
25
Dividend
0
AI Verdict
High Risk
Key drivers: Piotroski F-Score of 2/9, Negative earnings and revenue collapse, No analyst coverage, High forward P/E with negative earnings, Lack of Altman Z-Score data
Confidence
85%
Value
40/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of 1.49 is below 2.0, suggesting potential undervaluation on book value
  • Price/Sales of 0.77 is below 1.0, indicating low valuation relative to sales
Watchpoints
  • Graham Number not available due to negative earnings and lack of reliable data
  • Intrinsic value formula not applicable due to negative and volatile earnings
  • Forward P/E of 53.33 is extremely high for a company with negative earnings
Future
20/100

Ref Growth rates

Positives
  • Some recent quarters have beaten estimates (e.g., +36.4% surprise in 2025-05-07)
  • Positive earnings surprise in 2024-03-13 (+37.5%)
Watchpoints
  • Revenue growth is -65.8% YoY, indicating severe contraction
  • Earnings growth is -385.7% YoY, showing worsening profitability
  • No forward guidance or analyst estimates available
Past
55/100

Ref Historical trends

Positives
  • Historical earnings were positive and growing prior to 2023
  • Consistent earnings beats in 2020–2022 with ROE above 20% in some quarters
  • Strong 52-week high of $8.22 suggests prior market confidence
Watchpoints
  • Earnings collapsed from $0.43 in 2021 to -$1.54 in 2023-05-10 (surprise of -30,700%)
  • Negative earnings in 7 of the last 10 quarters
  • Most recent Q/Q EPS growth is -385.7%, indicating accelerating deterioration
Health
25/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Extremely low debt/equity ratio (0.02) reduces financial risk
  • High current and quick ratios (4.12 and 3.31) indicate strong liquidity
Watchpoints
  • Piotroski F-Score of 2/9 is critically low, indicating poor financial health
  • No Altman Z-Score available, but the combination of negative ROE, declining revenue, and negative earnings suggests distress risk
  • Negative ROA and ROE indicate inefficient use of assets and equity
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend yield and payout ratio are both N/A
  • No dividend has been paid, and the company is unprofitable
  • Negative earnings make dividend sustainability impossible

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.4

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BGSF and closest competitors.

Updated 2026-03-13
BGS
BGSF, Inc.
Primary
5Y
-38.0%
3Y
-19.3%
1Y
+151.7%
6M
+14.8%
1M
+9.6%
1W
+3.4%
SNT
Senstar Technologies Corporation
Peer
5Y
-3.3%
3Y
+104.7%
1Y
-4.1%
6M
-38.8%
1M
+2.7%
1W
+2.7%
SFW
Shengfeng Development Limited
Peer
5Y
-77.6%
3Y
-77.6%
1Y
0.0%
6M
-4.9%
1M
-4.3%
1W
-9.1%
HTC
High-Trend International Group
Peer
5Y
-96.3%
3Y
-59.6%
1Y
-66.0%
6M
+13.3%
1M
+1.8%
1W
-15.2%
XTI
XTI Aerospace, Inc.
Peer
5Y
-100.0%
3Y
-100.0%
1Y
+68.3%
6M
+38.4%
1M
-6.0%
1W
-19.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
53.33
PEG Ratio
N/A
P/B Ratio
1.49
P/S Ratio
0.77
EV/Revenue
0.58
EV/EBITDA
-6.92
Market Cap
$71.68M

Profitability

Profit margins and return metrics

Profit Margin -12.25%
Operating Margin -8.03%
Gross Margin 35.72%
ROE -17.69%
ROA -5.62%

Growth

Revenue and earnings growth rates

Revenue Growth -65.8%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.02
Low debt
Current Ratio
4.12
Strong
Quick Ratio
3.31
Excellent
Cash/Share
$1.69

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Revenue
$0.0B
Gross Margin
35.9%
Op. Margin
-5.2%
Net Margin
-21.6%
Total Assets
$0.1B
Liabilities
$0.0B
Equity
$0.1B
Debt/Equity
0.65x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
102%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-06
$N/A
2025-08-07
$-0.34
+22.7% surprise
2025-05-07
$-0.07
+36.4% surprise
2025-03-12
$-0.1
-25.0% surprise

Industrials Sector Comparison

Comparing BGSF against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
Return on Equity (ROE)
-17.69%
This Stock
vs
-19.38%
Sector Avg
-8.7% (Below Avg)
Profit Margin
-12.25%
This Stock
vs
6.65%
Sector Avg
-284.1% (Weaker)
Debt to Equity
0.02
This Stock
vs
2.63
Sector Avg
-99.1% (Less Debt)
Revenue Growth
-65.8%
This Stock
vs
71.29%
Sector Avg
-192.3% (Slower)
Current Ratio
4.12
This Stock
vs
3.09
Sector Avg
+33.3% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BAUM RICHARD L JR.
Director
Stock Award
2026-02-04
3,354 shares
HAILEY DOUGLAS E.
Director
Stock Award
2026-02-04
3,354 shares
CARROLL DONNA
Director
Stock Award
2026-02-04
3,354 shares
ALLEN CHARLES DAVID JR.
Director
Stock Award
2026-02-04
3,354 shares
SEID PAUL A
Director
Stock Award
2026-02-04
3,354 shares
BAUM RICHARD L JR.
Director
Stock Award
2025-11-05
5,482 shares
HAILEY DOUGLAS E.
Director
Stock Award
2025-11-05
5,482 shares
CARROLL DONNA
Director
Stock Award
2025-11-05
5,482 shares
ALLEN CHARLES DAVID JR.
Director
Stock Award
2025-11-05
5,482 shares
SEID PAUL A
Director
Stock Award
2025-11-05
5,482 shares
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning BGSF from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile